Skip to main navigation Skip to search Skip to main content

I9X-MC-MTAE: Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease

Project: Research

Project Details

StatusActive
Effective start/end date03/2/2206/28/26

Funding

  • Lilly USA LLC: $503,704.00